Pharmaceutical Companies and Profit

Pharmaceutical companies love the plasma trade. The global plasma-derived therapy market is worth billions, with no signs of slowing down. For these companies, paying donors is a cheap investment for the immense profits they generate from plasma-derived medications. Donors might make a quick buck, but the drugs created from plasma can sell for thousands of dollars. While companies get rich, the people providing this vital resource often struggle to pay rent or buy food.